Molina Healthcare (NYSE:MOH) Price Target Raised to $163.00 at Robert W. Baird

Molina Healthcare (NYSE:MOH) had its price target hoisted by investment analysts at Robert W. Baird from $124.00 to $163.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. Robert W. Baird’s price target would suggest a potential downside of 12.40% from the company’s previous close.

Several other equities analysts have also recently issued reports on the company. Barclays boosted their target price on Molina Healthcare from $133.00 to $161.00 and gave the stock an “underweight” rating in a research report on Friday, April 24th. Truist Financial boosted their target price on Molina Healthcare from $145.00 to $180.00 and gave the stock a “hold” rating in a research report on Monday, April 27th. UBS Group boosted their target price on Molina Healthcare from $151.00 to $180.00 and gave the stock a “neutral” rating in a research report on Friday, April 24th. Wells Fargo & Company boosted their target price on Molina Healthcare from $141.00 to $159.00 and gave the stock an “equal weight” rating in a research report on Monday, April 27th. Finally, Wall Street Zen upgraded Molina Healthcare from a “sell” rating to a “hold” rating in a research report on Saturday, May 2nd. Three equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $168.53.

Molina Healthcare Stock Performance

Shares of MOH stock opened at $186.07 on Monday. The stock has a market capitalization of $9.69 billion, a PE ratio of 55.05 and a beta of 0.85. Molina Healthcare has a 52-week low of $121.06 and a 52-week high of $333.00. The stock’s 50-day moving average price is $152.32 and its 200 day moving average price is $158.52. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.97.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.78. The firm had revenue of $10.80 billion for the quarter, compared to analysts’ expectations of $10.91 billion. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The firm’s revenue for the quarter was down 3.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.08 EPS. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, equities research analysts forecast that Molina Healthcare will post 5.21 EPS for the current year.

Institutional Investors Weigh In On Molina Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of MOH. Torren Management LLC acquired a new stake in shares of Molina Healthcare in the 4th quarter worth approximately $26,000. Miller Global Investments LLC acquired a new stake in shares of Molina Healthcare in the 4th quarter worth approximately $27,000. Physician Wealth Advisors Inc. grew its holdings in shares of Molina Healthcare by 1,250.0% in the 1st quarter. Physician Wealth Advisors Inc. now owns 216 shares of the company’s stock worth $29,000 after acquiring an additional 200 shares during the period. Cromwell Holdings LLC grew its holdings in shares of Molina Healthcare by 211.9% in the 4th quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock worth $32,000 after acquiring an additional 125 shares during the period. Finally, Quarry LP purchased a new stake in Molina Healthcare in the 4th quarter valued at approximately $32,000. Institutional investors and hedge funds own 98.50% of the company’s stock.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.